TY  - CONF

T1  - DNA damage response inhibitor combinations to enhance TTFields potency using clinically relevant ex-vivo glioblastoma models

PY  - 2022/01/01

AU  - Vanderlinden A

AU  - McGarrity-Cottrell C

AU  - Myers K

AU  - Carroll TA

AU  - Al-Tamimi Y

AU  - Rominiyi O

AU  - Collis S

ED  - 

DO  - DOI: 10.14791/btrt.2022.10.f-1187

SP  - s227

EP  - s221

Y2  - 2024/12/27

ER  -